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ABSTRACT 
Permeability of the Posterior Lens Capsule 
In Vitro and In Vivo 
Betty Rae Klein 
1986 
Extracapsular cataract surgery has resulted in increasing numbers of 
aphakic eyes with the posterior lens capsule present. According to recent 
clinical and experimental observations, an intact posterior lens capsule may 
increase the life expectancy of the aphakic eye by decreasing subsequent 
vitreal and retinal disease. 
We measured apparent permeability coefficients of rabbit and human 
posterior lens capsules in an in vitro diffusion chamber and by perfusion of 
living phakic and aphakic rabbit eyes. The mean permeability coefficients of 
isolated rabbit posterior lens capsules to fluorescein sodium (MW = 376) and 
three sizes of fluorescein labelled dextran (MW = 4000, 18,900, and 40,000) in 
-16 -16 -16 
vitro were 5.41 .728 x 10 , 6.35 +_ 4.41 x 10 , 4.32 + 1.24 x 10 , 
-i7 
and 7.61 + 1.58 x 10 mole/sec.dyne, respectively. The permeability 
coefficients of isolated human posterior lens capsules for fluorescein sodium, 
the 18,900 molecular weight dextran, and the 40,000 molecular weight dextran 
-16 -16 -17 
were 3.59 + 1.80 x 10 , 4.47 x 10 , and 1.65 + .165 x 10 

2 
mole/sec.dyne, respectively. Greater variability was observed in the 
permeability of human capsules compared to albino rabbit capsules. The 
relationship between solute flux and concentration was linear, consistent with 
the model of the capsule as an inert semipermeable membrane. 
The movement of fluorescein from the anterior chamber to the vitreous in 
intracamerally perfused living phakic eyes and aphakic eyes (with and without 
posterior capsulotomies) was investigated in rabbits. The permeability 
coefficient for living aphakic eyes with an intact posterior lens capsule 
-15 
(1.60 + 1.02 x 10 mole/sec.dyne) was three times greater than for 
-16 
isolated posterior lens capsules in vitro (5.41 + .728 x 10 
mole/sec.dyne). For living aphakic eyes with posterior capsulotomy, the 
-14 
permeability coefficient (7.30 + 6.65 x 10 mole/sec.dyne) was 135 times 
greater than for isolated posterior lens capsules and 46 times greater than in 
-15 




Surgical extraction is the only treatment presently available for 
cataracts. Intracapsular extraction involves removing the lens in toto along 
with its elastic lens capsule. Extracapsular cataract extraction consists of 
incision of the anterior lens capsule, expression of the lens nucleus through 
the corneal wound, and aspiration of the lens cortex from the posterior 
1 
chamber . The posterior lens capsule is thus preserved in extracapsular but 
not intracapsular cataract extraction. Cataract extraction can sometimes be 
followed by a variety of vitreoretinal complications including retinal breaks, 
2 
detachments, and cystoid macular edema . Preliminary studies indicate that 
aphakic eyes with an intact posterior lens capsule have a lower incidence of 
2 
posterior vitreous detachment and angiographically confirmed postoperative 
aphakic cystoid macular edema (ACME) than eyes having had intracapsular lens 
3,4 
extraction . When primary or secondary capsulotomy is performed either by 
surgical discission or Neodymium:YAG laser, the incidence of posterior 
2 5,6 
vitreous detachment and of ACME again become increased . The presence 
of an intact posterior lens capsule may reduce the frequency of post-operative 
retinal pathology and thus may help preserve a good visual result. 
The Posterior Lens Capsule and Cystoid Macular Edema 
Traction is a likely causative factor in the retinal tears and 
2 
detachments typically occurring after cataract surgery . However, there is 
7 
no conclusive evidence for the cause of aphakic cystoid macular edema . An 
8-10 
association between ACME and anterior segment inflammation and elevated 
11 
aqueous prostaglandin levels has been observed. The changes observed in 

4 
ACME could conceivably represent the actions of prostaglandin and/or other 
inflammatory substances diffusing posteriorly from the anterior segment after 
12-15 
cataract surgery . An intact posterior lens capsule may reduce the 
eye's susceptibility to cystoid macular edema by inhibiting movement of these 
12,14 
substances from the aqueous posteriorly to the retina . The relative 
contributions of the lens, posterior lens capsule, and surrounding zonule in 
inhibiting posterior diffusion of prostaglandins are not known. 
Cystoid macular edema is characterized by dilation of the perimacular 
capillaries and leakage of protein-rich fluid into the loosely structured and 
tangentially oriented outer plexiform and inner nuclear retinal 
16-19 
layers . An altered foveal reflex is noted on direct and indirect 
ophthalmoscopy while slit-lamp biomicroscopy discloses macular thickening and 
18 
the formation of microcystoid spaces . Fluorescein angiography in these 
eyes typically shows collection of fluorescein in these spaces in a petaloid 
18,20 
or rosette configuration 
Histologic changes in cystoid macular edema are suggestive of a 
21 
prostaglandin induced phenomenon . In the eye, prostaglandins cause 
22,23 
leukotaxis, vasodilatation, and increased vessel permeability . Aphakic 
18 
cystoid macular edema shows disruption of the blood-retinal barrier with 
leakage of serous exudate from intraretinal capillaries in the foveal 
16 
region 
Specialized cells regulate the volume and composition of the small 
24-26 
retinal extracellular spaces . The retinal vascular endothelium and 
retinal pigment epithelium have tight intercellular junctional complexes 
(zonula occludens) separating intravascular and extracellular fluid 
24,25 
media . In avascular regions of the retina the Muller cell is important 

5 
in distributing nutrients, removing waste products, and transporting 
18 
fluid . The foveal avascular zone has fewer Muller cells and higher local 
16,18,25,27 
tissue compliance than other parts of the retina . This 
predisposes the macular region to disturbances of extracellular fluid volume 
16 
and solute composition . Injury to the blood-retinal barrier and/or Muller 
16,28,29 28 30 
cell may result from ischemia , endogenous , or exogenous 
31,32 
agents, vitreous traction or a combination of these factors. 
Cystoid macular edema occurs with a variety of ocular conditions in 
9 
addition to cataract surgery . These include retinal surgery, uveitis, 
ocular tumors, diabetic retinopathy, senile macular degeneration, athero- 
8 10 
sclerotic vascular disease , retinitis pigmentosa , topical epinephrine 
33 
in aphakic eyes , nicotinic acid toxicity, radiation retinopathy, surface 
wrinkling retinopathy, choroidal lesions with submacular retinal pigment 
10 
epithelial defects, and idiopathic forms . The association of cystoid 
macular edema with a wide variety of conditions has suggested to some that it 
18 
represents a common macular response to diverse ocular diseases . Others 
contend that there are different varieties of cystoid macular edema depending 
34 13 
on the cause . Either way, there may be a common pathway for damage 
An association between post-cataract extraction cystoid macular edema 
12 19 
and both clinical and histologic retinal phlebitis, cyclitis and 
vitritis has been recognized. ACME is also more common in eyes with anterior 
segment complications of cataract extraction such as iris or vitreous 
8,10 
incarceration in the wound, retained lens cortex or uveitis which 
8-10 
produce mild inflammation of the ciliary body and vitreous . If this 




chemicals elaborated following ocular trauma , these same substances may 
be involved in the pathogenesis of aphakic cystoid macular edema. 
Inflammatory mediators transmitted by the vitreous may be more important in 
stimulating retinal vessels to leak than direct injury to the vessels 
8 
themselves . 
A recent clinical study investigated the role of ultraviolet light 
30 
exposure following cataract extraction in ACME . Placement of an 
ultraviolet absorbing chromophore in a posterior chamber intraocular lens 
reduced the incidence of postoperative cystoid macular edema (documented by 
30 
fluorescein angiography) by 50 percent . The mechanism underlying this 
phenomenon is not known. The release of prostaglandin in response to free 
radical production by the retinal pigment epithelium has been 
3,17 
postulated 
Miyake found elevated aqueous levels of prostaglandin E and F alpha 
35 2 
in eyes after intracapsular or extracapsular lens extraction . These 
35 
elevations were suppressed by pretreatment with topical indomethacin 
Elevated aqueous levels of prostaglandins E and F alpha detected in eyes 
2 
with persistent cystoid macular edema secondary to vitreous incarceration in 
11 
the surgical wound were reduced following vitrectomy . Clinically, 
inhibitors of prostaglandin synthesis have been effective in the prevention of 
7,15,36 
aphakic cystoid macular edema 
Although the above studies do not rule out the concurrent involvement of 
other endogenous substances produced in the eye (i.e. leukotriene, substance 
P, and ATP), they support the role of aqueous prostaglandins in the posterior 
segment pathology of ACME. 

7 
Efforts to induce prototypic cystoid macular edema in laboratory animals 
37-39 
have been unsuccessful . The association of CME with aphakia in humans 
most likely represents the combination of predisposing factors common to this 
39 
setting . Vascular fragility and inadequate tissue reparation may increase 
37,39 
the susceptibility of older patients to chronic cystoid maculopathy 
Mechanical factors such as traction secondary to forward movement of the 
vitreous and loss of hyaluronic acid from the vitreous leading to liquefaction 
20,31,32 
after intracapsular lensectomy may also play a role . Firm 
attachments of vitreous collagen to the retina are present at the macula, disc 
40 
margin, posterior surface of the posterior lens capsule, and pars plana 
These may predispose the macula to damage when the vitreous undergoes central 
2,20,32 
liquefaction . Although the inability to produce an animal model does 
13 
not exclude the possibility of a mediator-receptor interaction in ACME , it 
implies a variety of factors interacting in the clnical setting in which this 
39 
disease occurs 
The Posterior Lens Capsule and Iris Neovascularization 
Diabetic patients with retinal neovascularization have an increased 
incidence of developing neovascularization of the iris (rubeosis iridis) 
41,42 
following lensectomy with vitrectomy . Removal of the lens and vitreous 
may predispose patients to this condition by permitting anterior diffusion of 
43 41 
a vasoproliferative factor liberated from hypoxic retina . This inter¬ 
pretation is supported by studies showing a similar increase in iris rubeosis 
in eyes which are aphakic before undergoing vitrectomy and no predisposition 
43 
of eyes with cataracts to this disease . Although an effort is now made to 
preserve clear lenses in eyes undergoing vitrectomy for complications of 

8 
diabetic retinopathy, the barrier function of the lens-zonular diaphragm to 
potential angiogenic factors has not been experimentally determined. 
The retina may supply factors which stimulate the development of intra- 
44 
ocular neovascularization . Extracts from human and bovine retina have 
45 
produced vasoproliferation on chick chorioallantoic membrane . Vitreous 
46 
extracts have been shown to inhibit this neovascularization . Recently, 
retinal pigment epithelial cells in culture have been found to produce an 
47 
inhibitor of neovascularization . The growth of retinal vessels may depend 
on a balance of retina and RPE derived stimulators and vitreous derived 
44 
inhibitors 
A vasoproliferative factor liberated from hypoxic retina has been 
41 
postulated . New blood vessel development is associated with vascular 
48 
endothelial cell migration and increased incorporation of thymidine . A 
potent stimulator of endothelial cell thymidine uptake has been partially 
purified from bovine retina. This substance, an anion of greater than 50,000 
49 
dalton molecular weight , also has potent chemoattractant activity for 
50 
vascular endothelial cells in vitro . Putting these experimental findings 
together with clinical observations in patients with rubeosis iridis, a model 
is proposed whereby a retina derived substance diffuses anteriorly to 
41 
stimulate vascular endothelial growth on the iris . The increased incidence 
of rubeosis iridis in vitrectomized aphakic eyes may represent unopposed 




Barrier Function of the Posterior Lens Capsule 
The posterior lens capsule may inhibit the transport of some aqueous 
solutes from the anterior and posterior chambers into the vitreous 
12,14 51 
cavity and of vitreous components into the anterior segment 
Clinical and experimental data suggest that the posterior lens capsule 
2 
inhibits anterior displacement of the vitreous body and anterior diffusion 
51 
of hyaluronic acid, a vitreous structural molecule . In addition, an 
intact posterior lens capsule has been shown to decrease the extension of 
52 
bacterial infection from the anterior chamber into the vitreous cavity 
Whether or not an intact posterior lens capsule would reduce the 
susceptibility of eyes with retinal neovascularization to iris rubeosis is not 
known. 
The potential barrier functions of the posterior lens capsule, capsular- 
zonular diaphragm, lens-zonular diaphragm, and anterior hyaloid face are 
questions with important clinical implications. The access of aqueous 
substances to the retina and of vitreous substances to the anterior ocular 
structures in phakic and aphakic eyes has not been well studied. Under¬ 
standing the permeability characteristics of these structures may aid in 
12,14 41-43 
evaluating the above models for ACME and rubeosis iridis 

10 
MATERIALS AND METHODS 
In Vitro Experiments 
Paired plexiglass chambers were used for in vitro testing of posterior 
lens capsule permeability (Figure 1). The chambers were horizontally joined 
by four metal prongs which provided consistent, stable alignment. Two flat 
plexiglass discs (25 mm diameter, 5.0 mm thickness), each with a central 5.0 
mm round hole, fit into the opposing surfaces of each chamber over a flat 
rubber washer (Figure 2). The excised lens capsule was supported between two 
5.0 mm diameter rubber-o-rings fit into a shoulder surrounding the central 
hole in each plexiglass disc. When the apparatus was assembled, the chambers 
2 
communicated via a .071 cm aperture with a watertight seal. The integrity 
of this seal was tested using Parafilm between the rubber-o-rings, a 
fluorescein solution in one chamber, and distilled water in the opposite 
chamber. After 24 hours, there was no measurable fluorescence in the opposite 
chamber. An aquarium pump supplied a continuous stream of air into a narrow 
tube angled downward to each chamber [Figure 1 (arrow)] and provided constant 
stirring of solutions. Test solutions were added and samples removed via a 
vertical, cylindrical column (18 mm diameter, 25 mm height) communicating with 
each chamber. Evaporation was minimized by sealing the columns with Parafilm 
pierced by a 27 gauge needle for air escape. 
Twenty-three rabbit and nine human eyes were opened by posterior 
incision of the sclera (Figure 3). The zonular segments were disrupted using 
forceps (Figure 4). A lens loop was placed beneath the anterior surface of 

11 
the lens and the lens removed (Figure 5). A 360-degree equatorial incision 
was made in the lens capsule using a Vannas scissor (Figure 6). A rubber-o- 
ring was placed on the surface of the posterior lens capsule and cut edges 
were pushed up around its outer circumference (Figure 7). Forceps were used 
to lift the ring and adherent capsule, and residual cortex was removed by 
irrigation with distilled water. The rubber-o-ring was placed, capsule side 
down, on the rubber-o-ring of the opposite chamber (Figures 8 and 9). 
Chambers were assembled with each rubber-o-ring in its corresponding 
depression (Figure 10) and the capsule supported across the aperture between 
chambers. A tight fit was maintained with the chambers in horizontal position 
by metal brackets with tightening screws (Figure 11). 
A test solution containing either fluorescein or one of the higher 
molecular weight fluorescein-labelled dextrans was added to the chamber 
contacting the anterior surface of the posterior lens capsule. The opposite 
chamber was filled with an equal amount of distilled water. Broken capsules 
were readily recognized by rapid mixing of the two solutions and were 
discarded. At the experiment's start, a 1.0 ml sample from each side of the 
capsule was removed to a clear plastic cuvette and fluorescence measured in an 
Amico-Bowman spectrophotofluorometer. Each sample was then returned to its 
chamber. At recorded intervals of 1 to 2 hours, samples were measured and 
returned in a similar manner. The experiment was performed with solutions at 
room temperature (293) degrees Kelvin). 
For fluorescein, and for each of the fluorescein-labelled dextrans, a 
standard curve was constructed relating fluorescence to known solute 
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solution concentrations used. Linear regression analysis provided equations 
for calculating the concentration of fluorescein and fluorescein-labelled 
dextran solutions from measured fluorescence. 
In Vivo Experiments 
Albino rabbits were anesthetized with 1 to 2 ml of 20 mg/ml xylazine 
mixed in a 1:1 ratio with 100 mg/ml ketamine HC1 administered 
intramuscularly. Mydriasis was accomplished with phenylephrine HC1 2.5% 
(Neosynephrine) and tropicamide 1% (Mydriafair). Lens extraction was 
performed on the right eye of each rabbit. A partial thickness limbal 
incision was made with a No. 67 Beaver blade parallel to the superior limbus 
for 150 degrees. The cornea was penetrated at the center of the incision by a 
No. 75 Beaver blade and the anterior chamber was flushed with 0.1 ml of 1000 
USP units/ml heparin in BSS. A cystotome consisting of a bent tipped 27 gauge 
needle was inserted into the anterior chamber and the anterior lens capsule 
widely incised. The corneal incision was extended with corneoscleral scissors 
and the lens nucleus expressed through the wound. The cortex was irrigated 
from the anterior chamber using a blunt 23 gauge needle. In four of the 
rabbits, a large surgical posterior capsulotomy was performed. The wound was 
closed with a running 10-0 nylon suture. Topical gentamicin sulfate and 
corticosteroid were applied three times during the first hour after the 
operation. 
One to three months following lens extraction, the rabbits were 
premedicated with 526 mg of aspirin suppositories and anesthetized. Two 25 
gauge needles were placed intracamerally in each eye by tracking 1 to 2 mm 

13 
through the corneal stroma before entering the anterior chamber. One of the 
needles in each eye led, via polyethylene tubing, to a reservoir of saline at 
a height equivalent to 20 mm Hg and the other to a Harvard perfusion pump. 
The fluorescein solution was initially infused at a rate of 10 ml/min. The 
infusing solution was at room temperature. After three hours of perfusion, 
the aqueous was aspirated using a 27 gauge needle into a pre-weighed 
tuberculin syringe. The weight and volume of the aqueous aspirate was 
recorded and fluorescence measured. The anterior chamber was quickly flushed 
with normal saline. The animals were sacrificed and the eyes rapidly 
enucleated. The globes were immediately frozen in liquid nitrogen. 
The eyes were dissected while frozen. A Bard-Parker No. 15 blade was 
used to make a 360 degree perilimbal incision and to make four anteroposterior 
scleral incisions 90 degrees apart extending from the limbus to roughly 5 mm 
from the optic nerve. The anterior segment structures, including the lens in 
the phakic eyes, were removed as the sclera was peeled back. The frozen 
vitreous was transferred to a preweighed test tube. Samples of retina and 
choroid, optic nerve head, and sclera were also obtained and placed in weighed 
test tubes. Each tube was reweighed and the samples homogenized with 1 ml of 
normal saline. The tubes were placed in a centrifuge at 3650 rpm (2000 x 
gravity) for 15 minutes. The supernatant was transferred to a clear plastic 
cuvette and fluorescence measured. The fluorescein concentration in the 
original sample was then calculated. 
Levels of baseline fluorescence in aqueous, vitreous, retinal and 
choroid, optic nerve head and sclera were measured in four rabbit eyes using 




The equation for determining the apparent solute 
5 3 
permeability coefficient, w' is 
w' = Js (1) 
(RTdC) 
where Js, the solute flux is given by 
Js = dNs/dt (2) 
A 
and dNs/dt is the rate of change in concentration of the 
3 
solute on one side of the membrane in mol/cm sec; A is the 
2 
area of membrane available for diffusion in cm ; R is a gas 
7 o 
constant (8.31 x 10* erg/mol. K); T is the temperature in 
degrees Kelvin; and dC is the concentration gradient in 
3 
mol/cm . The units of w', the apparent solute permeability 
coefficient, are therefore mol/sec.dyne. 
The concentration gradient (dC) is the difference in 
solute concentration across the barrier. For the in vitro 
diffusion experiment, dC is the average difference in 
fluorescein or dextran concentration measured across the 
posterior lens capsule at one to two hour intervals. 
Because the rate of solute diffusion was small in relation 

15 
to the Initial test solution concentration and both chambers 
were constantly stirred, the concentration gradient was 
constant during the experiment. 
In the in vivo perfusion experiments the aqueous was 
stirred but not the vitreous. Accumulation of fluorescein 
in the anterior vitreous could reduce the effective 
concentration gradient in these eyes. Assuming that 
fluorescein accumulation occurred at a constant rate, dC was 
estimated by subtracting half of the final vitreous 
fluorescein concentration from the final aqueous 
concentration. 
The rate of concentration change (dNs/dt) is the 
concentration of solute moving through the barrier per unit 
time. In the in vitro experiment this was calculate by 
linear regression of solute concentration in the chamber on 
the posteior side of the lens capsule versus time. The rate 






Rabbit capsules [table 1] were significantly less 
permeable to 40,000 dalton dextran than to 18,900 dalton 
dextran (p< .025) or fluorescein sodium (MW = 376)(p< .001). 
However, differences in capsule permeability among solutes 
of molecular weight less than 18,900 were not significant. 
Human capsules [table 1] were significantly less 
permeable to 40,000 dalton dextran than to fluorescein 
sodium (p= .026). Human capsule permeability to 18,900 
dalton dextran was similar to fluorescein sodium; however, 
the number of subjects in this group was too small for 
statistical comparison. 
Human capsules were more permeable than rabbit capsules 
for 40,000 dalton dextran (p< .005). However, there were no 
significant differences between rabbit and human capsule 
permeability for dextrans of molecular weight equal to or 
less than 18,900. Greater individual variation in 
permeability was seen among human lens capsules than among 
albino rabbit capsules. 
The relation between solute flux, Js, and fluorescein 
concentration was examined for the isolated rabbit posterior 
lens capsules [graph 1]. This relationship was linear with 




IN VITRO EXPERIMENTS 
RABBIT CAPSULES 
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4 40000 7.61 + 1.58 X 10-17 
HUMAN CAPSULES 











376 3.59 + 1.80 x 10 

































































































In Vivo: [table 2] 
Mean apparent permeability coefficients for aphakic 
eyes with an intact posterior lens capsuls (ECCE/CI), for 
aphakic eyes with a large posterior capsulotomy (ECCE/CO), 
and for contralsfeicil phakic eyes belonging to each group 
(Phakic/CI) and (Phakic/CO) were calculated [table 3]. 
The mean permeability coefficient for aphakic eyes with 
a posterior capsulotomy (ECCE/CO) was 46 times greater than 
for aphakic eyes with an intact posterior lens capsule 
(ECCE/CI), although the variance was great. The mean 
apparent permeability coefficient for aphakic eyes with an 
intact posterior lens cpasule (ECCE/CI) was twice that of 
the contralateral phakic eyes in the same subjects 
(Phakic/CI). The ratio of mean coefficients for aphakic 
eyes with a posterior capsulotomy (ECCE/CO) to their 
contralateral phakic eyes ( Phakic/CO ) was 6. 
Additional comparisons were made between the apparent 
permeability coefficient of fluorescein for isolated rabbit 
“16 
posterior lens capsules in vitro (5.41 + .728 x 10 
mol/sec.dyne) and the values obtained by perfusion of 
-15 
aphakic eyes with (1.60 + 1.02 x 10 mol/sec.dyne = 
w'ECCE/CI) and without (7.30 + 6.65 x 10 14mol/sec.dyne = 
w'ECCE/CO) an intact posterior lens capsule in vivo. The 
apparent permeability coefficient of perfused living aphakic 
eyes with an intact posterior lens capsule (ECCE/CI) was 




IN VIVO EXPERIMENTS 
APPARENT PERMEABILITY COEFFICIENT, w' (mol/sec.dyne 







4,55 X 10-15 
2.12 X 10-16 
2.19 X 10-16 
1.42 X 10-15 
Phakic/CI(LE) % DIFF 
3.00 X 10-15 +52 
7.10 X 10-17 +199 
2.05 X 10-17 +968 
1.61 X 10-16 +782 
* % DIFF. = PERCENT DIFFERENCE = (w' ECCE/CI - w' 
Phakic/CI)/w' Phakic/CI x 100$. 
CAPSULOTOMY GROUP 
RABBIT ECCE/CO(RE) Phakic/CO(LE) % DIF F. 












VI 4.16 X 10-16 1.14 X 10-13 -64 
VII 2.72 X 10-13 1.94 X IQ-14 + 1302 







* % DIF F. = PERCENT DIFFERENCE = (w' ECCE/CO - w' Phakic/CO)/ 




Apparent permeabi1ity coefficient by intracameral perfusion 
of rabbit eyes with fluorescein (MW =376.28) solution. 







+ 1.02 x 10"15 







+ 6.65 x 10"14 
+ .677 x 10~14 6 : 1 
* 
ECCE/CI are aphakic eyes with an intact posterior lens 
capsule and Phakic/CI are contralateral phakic eyes in the 
same rabbits. ECCE/CO are aphakic eyes with a posterior 
capsulotomy and Phakic/CO are contraleteral phakic eyes in 
the same rabbits. 
TABLE 4 
Baseline Fluorescence in rabbit ocular tissue 
(nm of fluorescein-equivalents) 
AQUEOUS VITREOUS RETINA+CHQROID OPT N HEAD SCLERA 
0 .559 .4 
U .077 .1 
0 .550 .5 
0 1.00 1. 
55 .041 .041 





posterior lens capsule. This may represent fluorescein 
movement through the zonule; however, there was large 
variance in w' for ECCE/CI. In contrast, the apparent 
permeability coefficient for perfused aphakic eyes with a 
large posterior capsulotomy (ECCE/CO) exceeded the 
coefficient for the isolated posterior lens capsule by a 
factor of 135. 
Variable levels of baseline fluorescence were detected 
in the ocular tissues [table 4]. In general, fluorescence 
was highest in vascularized tissues. Vitreous fluorescence 
ranged from .077 to 1.00 nM fluorescein-equivalent in the 
four eyes tested. Variation in baseline fluorescence may 




The posterior lens capsule is a basement membrane 
54 
secreted by embryonic lens epithelium . It is composed of 
glycoprotein, with a 10 percent carbohydrate 
12 53 55 
content ' ' . Although the capsule contains enzymes, 
ATP, and glycolytic intermediates, it is not independently 
metabolically active54. The capsule is antigenically and 
chemically similar to the basement membranes of kidney 
54 56 
glomeruli, spleen, lung, and blood vessels ' 
The lens capsule is a composite membrane. Its 
increasing thickness with growth is contributed to by the 
57 
addition of layers . The lens capsule is thinnest at the 
poles and equator. The posterior lens capsule is thickest 
in an area 1 
5 8 
mm from the posterior pole The following 
measurements 
59 
were recorded by Salzmann in 1912: 
AGE(years) THICKNESS(mm) 
Post. Pole Post. Max. Equator 
2.5 2 18-22 7 
35 4 23 17 
71 2.3 9 9 
According to the above data, there is a decrease in 
posterior capsule thickness in later adulthood. 

22 
The permeability coefficient is a measurable quantity 
with complex molecular significance; it depends on the 
barrier's thickness, its composition, and on the diffusivity 
of the molecule through the barrier. Observation of the 
relative ability of solutes to cross the posterior lens 
capsule has been found by previous investigators to be a 
more accurate method of determining permeability than 
structural or chemical analysis of the barrier itself. 
In 1930 Freidenwald conducted the first investigation 
and cross species comparison of posterior lens capsule 
6 0 
permeability . After noting that the pores in the lens 
capsule are submicroscopic and that the capsule is 
negatively charged relative to physiologic saline solution, 
he proceeded to measure permeability empirically using 
6 0 
colloids, dyes, electrolytes, sugars and water . The 
capsules were freely permeable to electrolytes and sugars 
with permeability decreasing as molecular size increased. 
As one might predict given the capsule's negative charge, it 
is slightly more permeable to electropositive than 
electronegative colloids and nearly impermeable to neutral 
proteins60. Animal capsules were contnssted on the basis of 
their selectivity for tetrachlorphenolsulphonpthalein and 
vital red. Considerable individual variability existed 
among adult animals but the differences were not a large as 
between species60. Adult animal capsules were much less 
6 0 




Francois and Rabaey (1958) used microelectrophoresis 
on agar to test the permeability of the anterior ox lens 
capsule to lens proteins. The capsule was impermeable to 
alpha-crystalline (a high molecular weight protein) and to 
anionic, rapidly moving fractions. The capsule was highly 
permeable to the most basic fractions of medium molecular 
weight and to slow moving (less negatively charged), low 
molecular weight, embryonal protein fractions derived from 
the lens nucleus. This work demonstrates the importance of 
both molecular weight and polarity in determining a 
substance's ability to pass through the anterior lens 
capsule. 
Fels (1971) tested the permeability of isolated rabbit, 
53 
bovine, and human lens capsules to D- and L-tryptophan 
His interest in this question stemmed from studies by Ciusa 
6 2 63 
and Barbiroli ' in which 1-amino acids were absorbed by 
the lens more rapidly than the corresponding d-isomers. 
This had been interpreted to represent selectivity on the 
part of the lens capsule for 1-amino acids. Fels, however, 
found no significant difference in permeability between the 
two tryptophan isomers for any of the three species' lens 
capsules. Fels obtained an apparent permeability 
-17 
coefficient, w', of approximately 3 x 10 mol/sec.dyne for 
53 
tryptophan (MW = 204 daltons) . Whether anterior or 
posterior lens capsules were used was not specified. 
Ozaki quantified in vitro permeability of posterior 
lens capsules from human cataractuous and rabbit lenses to 
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10 C A 
methylmethacrylate monomer (MW 100) , glucose (MW 180) , 
3 
H-prostaglandin E (MW 354 ] 
64 3 
1 , H-prostaglandin F2alpha (MW 
354)64, epinephrine (MW 193 ; 
0 5 
, fluorescein sodium (MW 
376)12, and trypan blue (MW 961)65. Trypan blue had an 
-17 
apparent permeability coefficeint of w' = 10 mol/sec.dyne 
for the rabbit or human posterior lens capsules. 
Prostaglandin E and methylmethacrylate monomer, both 
hydrophobic substances, had permeability coefficients of w' 
-15 
= 10 mol/sec.dyne. The hydrophilic substances, 
prostaglandin F2alpha, fluorescein sodium, glucose and 
epinephrine had permeability coefficients of w' = 10 
15 
mol/sec.dyne*. The results of Ozaki's study indicate 
that the posterior lens capsule can function as a barrier to 
large non-electrolytes or negative electrolytes such as 
6 5 
lipids, hyaluronic acid, and enzymes . Molecular size and 
polarity in physiologic solutions were again important 
factors in determining the capsule's barrier function. 
Permeability was expressed in Dr. Ozaki's paper as a 
transfer coefficient-apparent permeability constant, k, 
which is related to the apparent permeability coefficient, 
w' , by 
k = w'RT at constant volume 
7 o 
where R = 8.31 x 10 erg/mol. K and T is the temperature in 
degrees Kelvin. The units of k are cm/sec. This conversion 




Thompson and Glaser Investigated the role of 
extracapsular lens extraction with and without posterior 
capsulotomy on the movement of 20,000 and 70,000 dalton 
tritiated dextrans from rabbit vitreous to aqueous jin 
£7 00 
vivo ' . The aqueous concentration of 20,000 dalton 
dextran 3.5 hours after intravitreal injection was increased 
14-fold after lensectomy with posterior capsulotomy and 10- 
fold after lensectomy with an intact posterior lens capsule. 
The rate of anterior movement of the 70,000 dalton dextran 
was increased fourfold in the eyes that had extracapsular 
lensectomy both with and without an intact posterior lens 
capsule. Thus, capsulotomy allowed increased movement of 
the 20,000 dalton dextran68. The abscence of a similar 
increase for the 70,000 dalton dextran may be related to a 
difference in sampling size or slowed diffusion of this 
6 8 
larger molecule through the vitreous 
The formula for determining the apparent permeability 
coefficient was designed for an inert semipermeable 
composite membrane. The membrane's thickness, composition 
or homogeneity need not be specified. Calculations are 
based on the initial concentration gradient across the 
membrane, the rate of change of concentration gradient, the 
area of membrane available for diffusion, and the 
temperature. These equations permitted in vitro study of 
the isolated posterior lens capsule and in vivo study of the 
lens-zonular diaphragm, capsular-zonular diaphragm, and 
anterior hyaloid face in a comparable, quantitative manner. 
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The equation derived by Kedem and Katchalsky (1958)53 
for determining the apparent solute permeability 
coefficient, w' is as follows: 
w' = Js/dPs 
Where dPs is the osmotic pressure difference69 across the 
membrane given by 
dPs = RTdC 
and Js is the solute flux given by 
Js = dNs/dt 
A 
Thus, the apparent permeability coefficient, w', is given by 
w1 = Js 
(RTdC) Jv=0 
The above formula applies only to experiments in which 
there is a constant solute flux (Js), or Jv=053,69. In a 
non-facilitated diffusion system the solute flux is 
dependent on the concentration gradient. Hence, Jv=0 only 
5 6 
when the concentration gradient is constant . Constant 
stirring and a large initial concentration gradient 
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(>10nm/ml) compared to the amount of solute diffusing 
through the membrane (<0.1nm/ml) prevented significant 
fluctuations in concentration gradient during the in vitro 
experiments. In the in vivo experiments, lack of stirring 
in the vitreous compartment made it more difficult to insure 
a constant effective concentration gradient. Assuming that 
fluorescein accumulation in the anterior vitreous occurred 
at a constant rate, the effective concentration gradient was 
estimated by subtracting half of the final vitreous 
concentration of fluorescein from the final aqueous 
concentration. In addition, the perfusion was limited to 
three hours. 
Even with constant stirring of the solutions on both 
sides of the membrane, an unstirred layer on the membrane's 
surface can interfere with accurate measurement of membrane 
permeability. Investigators have therefore preferred the 
term "apparent solute permeability coefficient, w'" to 
69 
"solute permeability coefficient, w" . The relation 
between w and w' is given by69 
1 = 1 + 2RTd 
w' w D 
where D is the diffusion coefficient in solution and d is 
the thickness of the unstirred layer. However, for slowly 
-15 
penetrating solutes (eg. those with w<10 mol/sec.dyne), 
this calculation may be neglected69. In these experiments, 
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w' was small enough to be considered equivalent to the 
solute permeability coefficient, w. 
The greater individual variability seen in the human in 
vitro data compared to the albino rabbit in vitro data may 
reflect greater homogeneity in a population of young, 
healthy albino rabbits. The human donor lens capsules were 
primarily from elderly individuals and neither the ocular 
nor the systemic histories of these eyes was available. In 
the case of human capsules, environmental, genetic, aging 
and disease processes may have influenced permeability. No 
significant differences were seen between the rabbit and 
human in vitro data except for the largest dextran. 
Both human and rabbit data showed decreasing 
permeability for solutes of increasing molecular weight. 
This supports the model of the capsule as a semipermeable 
membrane with selectivity on the basis of molecular size. 
Fluorescence in the vitreous of the perfused aphakic 
eyes with an intact posterior lens capsule exceeded that 
expected on the basis of the in vitro experiments. This 
difference is to large to be accounted for by the measured 
natural vitreous fluorescence. Hence, there appears to be 
fluorescein movement around the lens capsule, through the 
zonule. 
The presence of an intact posterior lens capsule 
reduced the permeability coefficient by a factor of 46 in 
aphakic eyes. Thus, fluorescein movement through the zonule 
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is not sufficient to abolish the relative barrier effect of 
the posterior lens capsule. 
The permeability coefficient for the capsular-zonular 
diaphragm was twice that of the lens-zonular diaphragm. 
— 1 
This difference (8 x 10 mol/sec.dyne) is of similar 
magnitude to the permeability coefficient of the isolated 
posterior lens capsule (5.41 x 10~16 mol/sec.dyne) and may 
represent fluorescein movement through the capsule, uptake 
of fluorescein by the lens in the phakic eye, and/or partial 
disruption of the zonular ligament resulting from the lens 
extraction procedure. 
Although the mean apparent permeability coefficient of 
aphakic perfused eyes with a posterior capsulotomy (ECCE/CO) 
was greater than the mean coefficient of contralateral 
phakic eyes (Phakic/CO), the reverse was true for several 
individual pairs of eyes [table 2]. This may represent 
back-diffusion of fluorescein into the aqueous through the 
capsulotomy. Clearly, whether fluorescein remains in the 
vitreous or returns to the aqueous in these eyes depends on 
a balance of forces including reistance of the anterior 
hyaloid face, and osmotic activity of fluorescein 
accumulating in the anterior vitreous as well as fluorescein 
in the anterior chamber. Nevertheless, when the difference 
between contralateral eyes was large, it was in the 




Individual variation in baseline fluorescence of the 
vitreous may have contributed both to the large statistical 
variance in the in vivo data and to the finding of higher in 
vivo apparent permeability coefficients compared to those 
for the isolated lens capsules. The large individual 
variability of this quantity made it impractical to use a 
correction factor in the in vivo experiments. Higher 
perfusion concentrations or the use of another tracer (ie. 
tritium) would have eliminated the influence of baseline 
fluorescence on experimental results and better duplicated 
the in vitro situation. 
Methods used here in determining permeability apply 
only to accellular, inert semipermeable membranes. The 
posterior lens capsule has been described as a 'coarse 
molecular screen1 lacking the selectivity of cellular 
membranes53,60. The solute flux (Js) or rate of 
concentration change per unit area of an inert semipermeable 
70 
membrane is linearly related to concentration gradient 
In contrast, facilitated diffusion systems (ie. cellular 
membranes) are characterized by diffusion curves which 
plateau and are described by a different kinetic model60,71. 
In these systems the solute flux is constant for 
concentration gradients above a critical value representing 
53 
saturation of the transport mechanism 
The capsule is constructed in staggered overlapping 
layers giving it an indeterminate surface area with a 
53 
variety of adsorbed, unstirred fluid layers . The 
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possibility of the lens capsule's heterogeneous lamellar 
structure interfering with its ability to conform to linear 
phenomenologic equations has been considered both here and 
co 7 0 
in previous investigations ' . Fels (1971) compared the 
solute flux for animal capsules to that of Visaing tubing, 
53 
an inert homogeneous man-made membrane . He found the 
solute flux to be linear for both with a latent period 
53 
preceeding linear flow in the case of human capsules . The 
relation between solute flux, Js, and fluorescein 
concentration was linear for in vitro rabbit capsule data 
[graph 1]. Hence, no evidence of facilitated or anomalous 
diffusion has been observed in this or previous studies with 
the posterior lens capsule12'60'61'64,65. 
In agreement with the empirical findings of 
g q 0 ^ 0 ^ 0 0 0 g 
Freidenwald0 , Francois0 , Ozaki° ' , and Thompson0 there 
was decreasing permeability with increasing molecular size. 
6 0 
However, in contrast to Freidenwald’s in vitro results 
permeabilities of rabbit and human capsules were similar 
except for the largest, 40,000 dalton dextran for which 
human capsules were more permeable. Also, the intra-species 
variability in capsule permeability noted by Freidenwald60 
was reproduced for the human data but not for the albino 
rabbit data. This last difference may reflect greater 
homogeneity of the subject population consisting only of 
albino rabbits of approximately the same age. 
53 
The value obtained by Fels for lens capsule 
-17 53 
permeability to tryptophan (w'=3 x 10 mol/sec.dyne ) 
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approximates the permeability of the highest molecular 
weight dextran (40,000 dalton) tested here. Tryptophan, a 
204 dalton molecular weight amino acid, has a non-polar R 
7 2 
group or side chain containing an aromatic ring . Its 
hydrophobic nature may explain the lens capsule's low 
permeability for this amino acid. 
Ozaki's apparent permeability coefficient of the 
posterior lens capsule to fluorescein (10-15mol/sec.dyne)64 
was greater than the one measured here (10 16mol/sec.dyne). 
The principle differences in experimental technique between 
the two studies are the use of a shorter incubation time of 
one hour and the use of artificial aqueous humor as a 
solvent by Ozaki. The effect of these difference on 
apparent permeability coefficient is not entirely clear; 
however, the shorter incubation time may have minimized the 
effect of an unstirred layer on the posterior surface of the 
lens capsule on effective concentration gradient. As the 
unstirred layer accumulates fluorescein it can 
artifact itiously diminish concentration gradient and thus 
permeability coefficient. 
Using intravitreal injections of 20,000 and 70,000 
dalton dextrans, Thompson and Glaser found greater aqueous 
levels of tracer in aphakic eyes with an intact posterior 
67 68 
lens capsule compared to phakic eyes ' . Similarly, there 
was more movement of fluorescein from aqueous into vitreous 
across the capsular-zonular diaphragm than across the lens- 
zonular diaphragm in the study performed here. Both of 
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these observations may represent tracer movement through the 
lens capsule, or through a partially disrupted zonule in the 
aphakic eye, or uptake of tracer by the lens in the phakic 
eye. Tracer movement across the len-zonular diaphragm in 
both Thompson and Glaser's experiments and in the in vivo 
fluorescein perfusion experiment reported here suggests 
movement of tacer through the zonule. These investigators 
also found a greater increase in anterior movement of 20,000 
dalton dextran in aphakic eyes with a posterior capsulotomy 
compared to aphakic eyes with an intact posterior lens 
67 68 
capsule ' . This is consistent with the in vivo perfusion 
data indicating the posterior lens capsule to be a relative 
barrier to the diffusion of tracers. The abscence of an 
observed difference in anterior diffusion of the 70,000 
dalton dextran among eyes with and without and intact 
posterior lens capsule may be secondary to slowed movement 
through the vitreous and may point out an advantage to 
studying posterior movement of smaller tracers from aqueous 
to vitreous. 
As aphakia becomes more common in the population, the 
potential barrier functions of the posterior lens capsule, 
capsular-zonular diaphragm, lens-zonular diaphragm, and 
anterior hyaloid face become important. An intact posterior 
lens capsule may reduce access of topical drugs, infectious 
52 1214 
agents , and aqueous substances ' to the retinal and 
vitreous. The capsular-zonular diaphragm may also limit the 
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_ . , 51,68 , 
access of vitreous , retina and retinal pigment 
epithelium derived substances to the anterior segment. 
By reducing diffusion of prostaglandins released into 
the aqueous to the vitreous, the capsular- zonular diaphragm 
may reduce the eye's susceptibility to aphakic cystoid 
12 14 
macular edema ' . Fluorescein and prostaglandins are of 
approximately equal molecular weight. In addition, they are 
both carboxylic acids and exist predominately in anionic 
form at physiologic pH. The data presented here show the 
capsular-zonular diaphragm to be a relative but not absolute 
barrier to fluorescein. Although the capsular-zonular 
diaphragm wa a less effective barrier to fluorescein than 
the lens-zonular diaphragm, it was more effective than the 
anterior vitreous face. The barrier effect of the capsule 
and surrounding zonule to prostaglandins may combine with 
physiologic mehanisms of aqueous clearance and prostaglandin 
deactivation to reduce access of these substances to the 
retina. This may explain the apparent relative protection 
provided by the intact posterior lens capsule against 
cystoid macular edema in aphakic patients12'14. 
Lensectomy increases the incidence of iris 
neovascularization in patients undergoing vitrectomy for 
41 42 
complications of diabetic retinopathy ' . This may 
represent removal of vitreous inhibitors of 
46 
vasoproliferation and loss of physical barriers to 
41 44 
anterior movement of retina ' and retinal pigment 
4 7 
epithelium derived stimulators of neovascularization. A 
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potential angiogenic factor isolated from bovine retina has 
been characterized as an anion of greater than 50,000 
41 48 49 50 
molecular weight ' ' ' . Combining the data collected 
here with previous studies on posterior lens capsule 
permeability, the capsular-zonular diaphragm can reduce 
anterior movement of an anion this size. Further studies 
regarding the influence of the lens, zonule and lens capsule 
on movement of angiogenic factors in the eye may clarify 
their etiologic role in iris rubeosis and enhance the 
clinical approach to diabetic patients needing vitrectomy 
and lens extraction. 
The method of measuring permeability employed in this 
study is empirical. An attempt was made.to obtain in vitro 
and in vivo data in a form permitting quantitative 
comparison. In the future, this approach may be useful in 
testing capsule permeability to other substances of interest 
in eye research. These substances may include endogenous 
inflammatory agents (ie. prostaglandins, leukotrienes, 
substance P, ATP, epinephrine), experimental angiogenic 
factors, topical and intracamerally administered 
pharmacologic agents, and pathogens (ie. viruses, bacteria, 
fungi). The experimental technique is also applicable to 
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